ZHX2-driven cell proliferation and migration were achieved though the activation of the MEK/ERK1/2 signaling pathway and the increasing VEGF expression, and led to Sunitinib resistance through regulating self-protective autophagy, providing a new insight for advanced ccRCC treatment [58]. The gene discussed is ZHX2; the disease is nonpapillary renal cell carcinoma.